Clinical Trials

492 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT06615479 2026-04-14

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

440 enrolled

Multiple Myeloma, Recurrence

NCT05438043 2026-04-13

A Study of Daratumumab

500 enrolled

Multiple Myeloma

NCT05572515 2026-04-13

MajesTEC-9

614 enrolled

Multiple Myeloma, Recurrence

NCT05552976 2026-04-01

SUCCESSOR-2

606 enrolled

Multiple Myeloma, Recurrence

NCT06413498 2026-03-27

iMMagine-3

450 enrolled

Multiple Myeloma

NCT06158841 2026-03-13

CERVINO

380 enrolled

Multiple Myeloma

NCT07391657 2026-03-12

DURGA-4

508 enrolled

Multiple Myeloma

NCT02659293 2026-03-04

Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma

180 enrolled

Multiple Myeloma

NCT03729804 2026-03-04

(COBRA)

250 enrolled

Multiple Myeloma

NCT03275285 2026-02-09

IKEMA

302 enrolled 38 charts 2 FDA

Multiple Myeloma

NCT05675319 2026-01-05

AlloRelapseMM

Phase 3 Terminated

28 enrolled

Multiple Myeloma

NCT01863550 2025-09-08

Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

1,087 enrolled

Multiple Myeloma

NCT03158688 2025-05-09

CANDOR

466 enrolled 33 charts 3 FDA

Multiple Myeloma

NCT04096066 2025-01-15

KRdvsRd

84 enrolled

Multiple Myeloma

NCT04934475 2024-11-07

MIDAS

791 enrolled

Multiple Myeloma

NCT03859427 2024-08-13

ARROW2

454 enrolled 24 charts

Multiple Myeloma, Recurrence, Bone Marrow Neoplasms

NCT06232707 2024-05-31

ALUMMINATE

Phase 3 Withdrawn

Multiple Myeloma, Recurrence

NCT03948035 2023-05-06

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

576 enrolled

Multiple Myeloma

NCT03651128 2022-12-15

KarMMa-3

381 enrolled

Multiple Myeloma, Recurrence

NCT01568866 2022-11-14

ENDEAVOR

929 enrolled 21 charts

Multiple Myeloma

NCT02412878 2022-09-23

ARROW

478 enrolled 17 charts

Multiple Myeloma

NCT01080391 2022-09-21

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

792 enrolled 18 charts

Multiple Myeloma

NCT03029234 2022-05-25

Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma

126 enrolled 30 charts

Multiple Myeloma, Recurrence

NCT04288765 2021-07-09

Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Phase 3 Withdrawn

Multiple Myeloma

NCT01818752 2019-08-26

CLARION

955 enrolled 20 charts

Multiple Myeloma

NCT01554852 2018-06-11

Myeloma XI

Phase 3 Unknown

4,420 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01302392 2017-05-02

FOCUS

315 enrolled 18 charts